At its meeting on 1 February, 2017, the People Overview and Scrutiny Committee referred the Scrutiny Review on Community Pharmacies to the Cabinet. A covering report, Overview and Scrutiny Committee minute and the Scrutiny Review are attached.

Councillor Ann McLachlan introduced a report which informed that the Government had set out initial proposals for community pharmacies in 2016/17 and beyond in an open letter dated 17 December 2015 to the Pharmaceutical Services Negotiating Committee (PSNC) and other stakeholders.  The proposals had included revised contractual and funding arrangements.  A period of formal consultation ended on 24 May 2016, although confidential discussions continued beyond that date.

Following a Notice of Motion to the Council in July 2016, this issue had been referred to the People Overview and Scrutiny Committee for further consideration.  On the advice of NHS England, it had not been practical to commence a detailed scrutiny review immediately, as the Government had not, at that time, made a formal response to the consultation nor provided detailed proposals regarding the future contractual and financial arrangements for community pharmacies. 

Once the Government’s final proposals were made public in October 2016, a Scrutiny Review Panel had met in November to consider the potential impact of the changes to Wirral.  The report documented the findings.  On 1 February 2017, the report was approved by the People Overview and Scrutiny Committee and referred to the Cabinet for further consideration. 

This matter affected all Wards within the Borough. It was not a key decision.

Councillor McLachlan invited Councillor Phil Gilchrist, a Member of the Scrutiny review Panel, who was in attendance at the meeting, to speak on the report.

Councillor Gilchrist reported that Pharmacies were often the first port of call for medication when people were unwell and that they were rooted and embedded within local communities.  It was expected that the Pharmacy Funding Settlement would result in national spending of £2.687 billion (a 4% reduction) in 2016/17 and £2.592 billion (a further 3.4% reduction in 2017/18).  The funding changes would result in a simplification of the fees structure, including consolidation of fees into a single activity fee and phasing out of establishment fees.  At the same time, the Pharmacy Access Scheme (PhAS) was being introduced to support access where pharmacies were sparsely spread and patients depended on them the most. However, key among the criteria for eligibility to the new access scheme was that a pharmacy must be more than one mile from the next nearest pharmacy. Initial indications were that, at a national level, 1356 pharmacies would receive funding from the PhAS on the basis of these criteria. However, only four of these were in Wirral.  Social deprivation was not given any weight under this scheme.

Councillor Janette Williamson informed that the impact to local communities was yet to be established and the judicial reviews relating to the changes  ...  view the full minutes text for item 109